Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
818 Combination therapy with anti-PD1 and anti-LAG3 leads to unique peripheral and intratumoral CD8+ T cells signatures in patients with metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.